资讯

The Pharma Letter17 小时
The week in pharma: action, reaction and insight – week to August 1
Among last week’s news, US biotech Celcuity leapt 180% on new Phase III data for its cancer drug candidate gedatolisib. US drugmaker Madrigal Pharmaceuticals entered into a licensing deal with China’s ...